Journal
CANCER DISCOVERY
Volume 3, Issue 12, Pages 1339-1344Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-13-0394
Keywords
-
Categories
Funding
- NCI NIH HHS [U01 CA141508-05, R01 CA93947-10, U01 CA141508, R01 CA093947] Funding Source: Medline
Ask authors/readers for more resources
The identification of evidence-based, efficacious drug combinations for each cancer, among thousands of potential permutations, is a daunting task. In this perspective, we propose a systematic approach to defining such combinations by molecularly benchmarking a drug against a desired state of efficacy using model systems. (C) 2013 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
